Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
2,873
-
Share change
-
-13,916
-
Total reported value
-
$9,364
-
Price per share
-
$3.00
-
Number of holders
-
13
-
Value change
-
-$69,102
-
Number of sells
-
4
Institutional Holders of TITAN PHARMACEUTICALS INC - COM NEW (TTNP) as of Q4 2024
As of 31 Dec 2024,
TITAN PHARMACEUTICALS INC - COM NEW (TTNP) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,873 shares.
The largest 10 holders included
UBS Group AG, MCF Advisors LLC, BANK OF AMERICA CORP /DE/, OSAIC HOLDINGS, INC., GROUP ONE TRADING LLC, MORGAN STANLEY, Global Wealth Strategies & Associates, Nemes Rush Group LLC, WELLS FARGO & COMPANY/MN, and CALDWELL SUTTER CAPITAL, INC..
This page lists
15
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.